These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 57828)

  • 1. Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient.
    Bhattacharya M; Chatterjee SK; Barlow JJ
    Cancer Res; 1976 Jun; 36(6):2096-101. PubMed ID: 57828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosyltransferase and glycosidase activities in ovarian cancer patients.
    Chatterjee SK; Bhattacharya M; Barlow JJ
    Cancer Res; 1979 Jun; 39(6 Pt 1):1943-51. PubMed ID: 445394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of serum glycoprotein galactosyltransferase levels in different histological types of ovarian carcinoma.
    Gauduchon P; Tillier C; Guyonnet C; Heron JF; Bar-Guilloux E; Le Talaer JY
    Cancer Res; 1983 Sep; 43(9):4491-6. PubMed ID: 6409405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of products synthesized by galactosyltransferase purified from the ascites of ovarian cancer patients.
    Chatterjee SK; Bhattacharya M; Barlow JJ
    J Natl Cancer Inst; 1986 Oct; 77(4):855-62. PubMed ID: 2429004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor markers for ovarian cancer.
    Bhattacharya M; Barlow JJ
    Int Adv Surg Oncol; 1979; 2():155-76. PubMed ID: 95453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uridine 5'-diphosphate galactose: glycoprotein galactosyl transferase activity in exfoliated bladder epithelial cells in rats fed N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide.
    Plotkin GM; Brigham SC; Wolf G; Jacobs JB; Arai M
    Cancer Biochem Biophys; 1977; 2(2):59-63. PubMed ID: 99227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine monoclonal antibodies against galactosyltransferase from the ascites of ovarian cancer patients.
    Chatterjee SK; Bhattacharya M; Barlow JJ
    Cancer Res; 1984 Dec; 44(12 Pt 1):5725-32. PubMed ID: 6209001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Localization and modulation of galactosyltransferase during in vitro proliferation of a human ovarian adenocarcinoma cell line].
    Sichel F; Bar E; Gauduchon P; Malas JP; Benard J; Le Talaer JY
    C R Acad Sci III; 1991; 312(1):19-24. PubMed ID: 1900729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies on the uridine-5'-diphosphate-galactose: glycoprotein galactosyltransferase activity in rat liver and Zajdela ascitic hepatoma.
    Ivanov D; Karaivanova V; Ivanov S; Chelibonova-Lorer H
    Cancer Biochem Biophys; 1994 Apr; 14(1):35-40. PubMed ID: 7540947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and immunoassay of human tumor-associated galactosyltransferase isoenzyme II.
    Uemura M; Winant RC; Sikic BI; Brandt AE
    Cancer Res; 1988 Sep; 48(18):5325-34. PubMed ID: 3136919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of two distinct galactosyltransferase activities in populations of mouse peritoneal macrophages.
    Sheares BT; Mercurio AM
    J Immunol; 1987 Dec; 139(11):3748-52. PubMed ID: 3119716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase.
    Saitoh E; Aoki D; Susumu N; Udagawa Y; Nozawa S
    Int J Oncol; 2003 Aug; 23(2):303-10. PubMed ID: 12851678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative differences in GlcNAc:beta1-->3 and GlcNAc:beta1-->4 galactosyltransferase activities between human colonic adenocarcinomas and normal colonic mucosa.
    Seko A; Ohkura T; Kitamura H; Yonezawa S; Sato E; Yamashita K
    Cancer Res; 1996 Aug; 56(15):3468-73. PubMed ID: 8758913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of 4 beta-galactosyltransferase activity for paragloboside synthesis in sera of patients with cancer.
    Nishiwaki S; Taki T; Handa N; Hattori N; Takeshita K; Endo M; Handa S
    Cancer Res; 1992 Apr; 52(7):1875-80. PubMed ID: 1551117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the purification and properties of UDP-galactose glycoprotein galactosyltransferase from rat liver and serum.
    Fraser IH; Mookerjea S
    Biochem J; 1976 May; 156(2):347-55. PubMed ID: 821479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoassay of serum galactosyltransferase isoenzyme II in cancer patients and control subjects.
    Uemura M; Winant RC; Brandt AE
    Cancer Res; 1988 Sep; 48(18):5335-41. PubMed ID: 3136920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and immunologic characterization of galactosyltransferase purified from the ascites of ovarian cancer patients.
    Chatterjee SK; Bhattacharya M; Barlow JJ
    J Natl Cancer Inst; 1985 Aug; 75(2):237-48. PubMed ID: 3927048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated thymic and serum galactosyltransferase with low-molecular-weight acceptor activity in murine leukemia.
    Krishnaraj R; Saat YA
    Cancer Res; 1985 Aug; 45(8):3615-9. PubMed ID: 3926305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma.
    Nozawa S; Yajima M; Sakuma T; Udagawa Y; Kiguchi K; Sakayori M; Narisawa S; Iizuka R; Uemura M
    Cancer Res; 1990 Feb; 50(3):754-9. PubMed ID: 2105162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of glycoprotein galactosyltransferase activity in human lung cancer related to histological types.
    Kijimoto-Ochiai S; Makita A; Kameya T; Kodama T; Araki E; Yoneyama T
    Cancer Res; 1981 Jul; 41(7):2931-5. PubMed ID: 6788364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.